Lone Star Funds acquire Capsules & Health Ingredients division of Lonza Group AG

Lone Star Funds announced that an affiliate of Lone Star Fund XII, L.P. entered into a definitive agreement to acquire the Capsules & Health Ingredients (CHI) division of Lonza Group AG for an enterprise value of CHF 2.3 billion. As part of the transaction, Lonza will retain a 40% equity position in the business. Headquartered in Basel, Switzerland, CHI operates globally across the Americas, Europe and Asia Pacific. The transaction is subject to customary closing conditions and expected to close in the second half of 2026.

Lenz & Staehelin is advising Lone Star in this transaction. The team is led by Tino Gaberthüel and Simone Ehrsam (both Corporate and M&A) and includes Raphael Fries, Nils Maag (both Corporate and M&A), Peter Ling, Lena Dürwald (both IP) and Franziska Stadtherr-Glättli (Social Security, Pension, Tax).